scholarly journals Cell-free DNA as a second screen after positive quad screen for trisomy 13:A cost-effectiveness analysis

2022 ◽  
Vol 226 (1) ◽  
pp. S369
Author(s):  
Uma Doshi ◽  
Carmen M. Avram ◽  
Claire H. Packer ◽  
Aaron B. Caughey
Keyword(s):  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Trisomy 13 ◽  
Cell Free Dna ◽  
Second Screen ◽  
Free Dna ◽  
Effectiveness Analysis

A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome

2015 ◽  
Vol 35 (5) ◽  
pp. 440-446 ◽  
Author(s):  
Brandon S. Walker ◽  
Brian R. Jackson ◽  
Danielle LaGrave ◽  
Edward R. Ashwood ◽  
Robert L. Schmidt
Keyword(s):  
Down Syndrome ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Cell Free Dna ◽  
Free Dna ◽  
Effectiveness Analysis ◽  
Serum Screening

Cell-Free DNA–Based Non-invasive Prenatal Screening for Common Aneuploidies in a Canadian Province: A Cost-Effectiveness Analysis

2018 ◽  
Vol 40 (1) ◽  
pp. 48-60 ◽  
Author(s):  
Léon Nshimyumukiza ◽  
Jean-Alexandre Beaumont ◽  
Julie Duplantie ◽  
Sylvie Langlois ◽  
Julian Little ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Prenatal Screening ◽  
Cost Effectiveness Analysis ◽  
Canadian Province ◽  
Cell Free Dna ◽  
Non Invasive ◽  
Free Dna ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document